Susquehanna International Group’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $582K | Sell |
51,238
-52,541
| -51% | -$596K | ﹤0.01% | 4112 |
|
|
2025
Q1 | $690K | Sell |
103,779
-84,129
| -45% | -$559K | ﹤0.01% | 3897 |
|
|
2024
Q4 | $2.07M | Buy |
187,908
+53,767
| +40% | +$593K | ﹤0.01% | 1934 |
|
|
2024
Q3 | $1.65M | Buy |
134,141
+123,914
| +1,212% | +$1.52M | ﹤0.01% | 2074 |
|
|
2024
Q2 | $138K | Sell |
10,227
-69,299
| -87% | -$936K | ﹤0.01% | 4967 |
|
|
2024
Q1 | $1.07M | Buy |
79,526
+58,242
| +274% | +$786K | ﹤0.01% | 2544 |
|
|
2023
Q4 | $112K | Sell |
21,284
-50,957
| -71% | -$268K | ﹤0.01% | 5301 |
|
|
2023
Q3 | $285K | Buy |
72,241
+44,754
| +163% | +$176K | ﹤0.01% | 4098 |
|
|
2023
Q2 | $292K | Buy |
27,487
+11,965
| +77% | +$127K | ﹤0.01% | 4256 |
|
|
2023
Q1 | $129K | Buy |
+15,522
| New | +$129K | ﹤0.01% | 5126 |
|
|
2022
Q2 | – | Sell |
-14,409
| Closed | -$303K | – | 6628 |
|
|
2022
Q1 | $303K | Sell |
14,409
-13,681
| -49% | -$288K | ﹤0.01% | 4339 |
|
|
2021
Q4 | $674K | Buy |
28,090
+7,042
| +33% | +$169K | ﹤0.01% | 3400 |
|
|
2021
Q3 | $535K | Buy |
21,048
+9,606
| +84% | +$244K | ﹤0.01% | 3603 |
|
|
2021
Q2 | $385K | Sell |
11,442
-18,231
| -61% | -$613K | ﹤0.01% | 4195 |
|
|
2021
Q1 | $1.15M | Buy |
29,673
+22,782
| +331% | +$884K | ﹤0.01% | 2806 |
|
|
2020
Q4 | $427K | Sell |
6,891
-3,876
| -36% | -$240K | ﹤0.01% | 3568 |
|
|
2020
Q3 | $361K | Buy |
+10,767
| New | +$361K | ﹤0.01% | 3332 |
|
|
2020
Q2 | – | Sell |
-12,861
| Closed | -$295K | – | 4891 |
|
|
2020
Q1 | $295K | Buy |
+12,861
| New | +$295K | ﹤0.01% | 3446 |
|